Efficacy and Safety of Auto-FMT in Preventing aGVHD | MicrobiomeTrials← Back to trialsNCT04745221
Efficacy and Safety of Auto-FMT in Preventing aGVHD
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2021-03-01Est. Completion: 2027-03-01
Enrollment target: 100 participants Locations- Ye Zhao, Suzhou, Jiangsu, China
Other microbiome trials you might be interested in
Prostate CancerOligo-metastatic Prostate CarcinomaOligometastatic CancerNodal Oligorecurrent Prostate Cancer
This single-arm phase 2 trial investigates whether a single high-dose radiotherapy treatment can safely treat men whose …
Odense, DenmarkEst. completion Apr 2030
Pancreatitis, Chronic; Diabetes; Transplant
Patients with severe chronic pancreatitis may be candidates to have their pancreas removed and their islets transplanted…
Minneapolis, United StatesCompleted Jul 1, 2023
CoronaryCoronary Artery Disease
The CAPRA-EVO trial is a single-center, randomized, open-label study with blinded endpoint assessment comparing early ev…
Chengdu, ChinaEst. completion Dec 31, 2028